<DOC>
	<DOCNO>NCT02912351</DOCNO>
	<brief_summary>This retrospective , single-site observational study , design assess clinical outcome collect safety data GMK Revision knee system use primary revision total knee arthroplasty minimum two year post-treatment .</brief_summary>
	<brief_title>A Post-Market Retrospective Study Revision Total Knee Arthroplasty Using Medacta GMKÂ® Revision Prosthesis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patients willing able provide write informed consent participation study . Written informed consent must obtain prior study procedure . Patients ability understand provide write authorization use disclosure personal health information Patients must willing comply postoperative evaluation schedule . Patients underwent either primary revision total knee replacement type etiology ( Osteoarthritis , Avascular necrosis , Rheumatoid Arthritis , Posttraumatic Arthritis , Polyarthritis , Primary implantation failure ) . Patients must receive GMK Revision component Patients must minimum 2 year ( 24 month ) posttreatment The operation perform supervised investigator . No age limit criterion History alcoholism Currently chemotherapy radiation therapy Habitual use narcotic pain medication prior surgery surgery reason knee pain History metabolic disorder affect skeletal system osteoarthritis osteoporosis History chronic pain issue reason knee pain Women pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Total Knee Arthroplasty</keyword>
	<keyword>Total Knee Replacement</keyword>
	<keyword>Revision Knee Arthroplasty</keyword>
</DOC>